{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:17:50Z","timestamp":1790320670684,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41390-023-02489-2","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T20:03:32Z","timestamp":1675281812000},"page":"512-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model"],"prefix":"10.1038","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-5548","authenticated-orcid":false,"given":"Aline U.","family":"Bjerkhaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegunn N.","family":"Granslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorunn Pauline","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"H\u00f8iland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Krey","family":"Ludviksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Espevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Eirik","family":"Mollnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Klingenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"2489_CR1","doi-asserted-by":"crossref","first-page":"F220","DOI":"10.1136\/adc.2002.022863","volume":"90","author":"S Vergnano","year":"2005","unstructured":"Vergnano, S., Sharland, M., Kazembe, P., Mwansambo, C. & Heath, P. Neonatal sepsis: an international perspective. Arch. Dis. Child. Fetal Neonatal Ed. 90, F220\u2013F224 (2005).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2489_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2471\/BLT.14.139790","volume":"93","author":"S Oza","year":"2014","unstructured":"Oza, S., Lawn, J. E., Hogan, D. R., Mathers, C. & Cousens, S. N. Neonatal Cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000\u20132013. Bull. World Health Organ. 93, 19\u201328 (2014).","journal-title":"Bull. World Health Organ."},{"key":"2489_CR3","doi-asserted-by":"crossref","first-page":"e200593","DOI":"10.1001\/jamapediatrics.2020.0593","volume":"174","author":"BJ Stoll","year":"2020","unstructured":"Stoll, B. J. et al. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 174, e200593 (2020).","journal-title":"JAMA Pediatr."},{"key":"2489_CR4","doi-asserted-by":"crossref","first-page":"e2021052456","DOI":"10.1542\/peds.2021-052456","volume":"148","author":"DD Flannery","year":"2021","unstructured":"Flannery, D. D., Edwards, E. M., Puopolo, K. M. & Horbar, J. D. Early-onset sepsis among very preterm infants. Pediatrics 148, e2021052456 (2021).","journal-title":"Pediatrics"},{"key":"2489_CR5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1542\/peds.2009-3301","volume":"125","author":"J Wynn","year":"2010","unstructured":"Wynn, J., Cornell, T. T., Wong, H. R., Shanley, T. P. & Wheeler, D. S. The host response to sepsis and developmental impact. Pediatrics 125, 1031\u20131041 (2010).","journal-title":"Pediatrics"},{"key":"2489_CR6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","volume":"18","author":"G Hajishengallis","year":"2017","unstructured":"Hajishengallis, G., Reis, E. S., Mastellos, D. C., Ricklin, D. & Lambris, J. D. Novel mechanisms and functions of complement. Nat. Immunol. 18, 1288\u20131298 (2017).","journal-title":"Nat. Immunol."},{"key":"2489_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4049\/jimmunol.1501954","volume":"196","author":"G Pietrocola","year":"2016","unstructured":"Pietrocola, G. et al. The group B streptococcus\u2013secreted protein Cip interacts with C4, preventing C3b deposition via the lectin and classical complement pathways. J. Immunol. 196, 385\u2013394 (2016).","journal-title":"J. Immunol."},{"key":"2489_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1269","volume":"4","author":"PA Ward","year":"2004","unstructured":"Ward, P. A. The dark side of C5a in sepsis. Nat. Rev. Immunol. 4, 133\u2013142 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"2489_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000316286","volume":"2","author":"HK De Jong","year":"2010","unstructured":"De Jong, H. K., Van Der Poll, T. & Wiersinga, W. J. The systemic pro-inflammatory response in sepsis. J. Innate Immun. 2, 422\u2013430 (2010).","journal-title":"J. Innate Immun."},{"key":"2489_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"key":"2489_CR11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.micpath.2017.03.042","volume":"107","author":"N Chauhan","year":"2017","unstructured":"Chauhan, N., Tiwari, S. & Jain, U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb. Pathog. 107, 234\u2013242 (2017).","journal-title":"Microb. Pathog."},{"key":"2489_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1189\/jlb.3VMR0316-132R","volume":"101","author":"A Barratt\u2010Due","year":"2017","unstructured":"Barratt\u2010Due, A., Pischke, S. E., Nilsson, P. H., Espevik, T. & Mollnes, T. E. Dual inhibition of complement and toll\u2010like receptors as a novel approach to treat inflammatory diseases\u2014C3 or C5 emerge together with CD14 as promising targets. J. Leukoc. Biol. 101, 193\u2013204 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"2489_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fped.2018.00199","volume":"6","author":"SS Sch\u00fcller","year":"2018","unstructured":"Sch\u00fcller, S. S. et al. Immunomodulation to prevent or treat neonatal sepsis: past, present, and future. Front. Pediatr. 6, 199 (2018).","journal-title":"Front. Pediatr."},{"key":"2489_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clp.2010.04.001","volume":"37","author":"JL Wynn","year":"2010","unstructured":"Wynn, J. L. & Levy, O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin. Perinatol. 37, 307\u2013337 (2010).","journal-title":"Clin. Perinatol."},{"key":"2489_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1189\/jlb.0907656","volume":"84","author":"NJ Nilsen","year":"2008","unstructured":"Nilsen, N. J. et al. Cellular trafficking of lipoteichoic acid and toll\u2010like receptor 2 in relation to signaling; role of CD14 and CD36. J. Leukoc. Biol. 84, 280\u2013291 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"2489_CR16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1189\/jlb.0803360","volume":"75","author":"S Lotz","year":"2004","unstructured":"Lotz, S. et al. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 75, 467\u2013477 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"2489_CR17","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.4049\/jimmunol.1300755","volume":"192","author":"EW Skjeflo","year":"2014","unstructured":"Skjeflo, E. W., Christiansen, D., Espevik, T., Nielsen, E. W. & Mollnes, T. E. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model. J. Immunol. 192, 2857\u20132864 (2014).","journal-title":"J. Immunol."},{"key":"2489_CR18","doi-asserted-by":"crossref","first-page":"e20182894","DOI":"10.1542\/peds.2018-2894","volume":"142","author":"KM Puopolo","year":"2018","unstructured":"Puopolo, K. M., Benitz, W. E., Zaoutis, T. E. & Diseases, C. O. I. Management of neonates born at \u2265 35 0\/7 weeks\u2019 gestation with suspected or proven early-onset bacterial sepsis. Pediatrics 142, e20182894 (2018).","journal-title":"Pediatrics"},{"key":"2489_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fped.2018.00285","volume":"6","author":"C Klingenberg","year":"2018","unstructured":"Klingenberg, C., Kornelisse, R. F., Buonocore, G., Maier, R. F. & Stocker, M. Culture-negative early-onset neonatal sepsis\u2014at the crossroad between efficient sepsis care and antimicrobial stewardship. Front. Pediatr. 6, 285 (2018).","journal-title":"Front. Pediatr."},{"key":"2489_CR20","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.molimm.2008.05.017","volume":"45","author":"O-L Brekke","year":"2008","unstructured":"Brekke, O.-L. et al. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine-and growth factor-synthesis in human whole blood. Mol. Immunol. 45, 3804\u20133813 (2008).","journal-title":"Mol. Immunol."},{"key":"2489_CR21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/IAI.01305-08","volume":"77","author":"EB Thorgersen","year":"2009","unstructured":"Thorgersen, E. B. et al. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood. Infect. Immun. 77, 725\u2013732 (2009).","journal-title":"Infect. Immun."},{"key":"2489_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1753425913482993","volume":"20","author":"KH Egge","year":"2014","unstructured":"Egge, K. H. et al. Post challenge inhibition of C3 and CD14 attenuates Escherichia coli-induced inflammation in human whole blood. Innate Immun. 20, 68\u201377 (2014).","journal-title":"Innate Immun."},{"key":"2489_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cei.12645","volume":"181","author":"KH Egge","year":"2015","unstructured":"Egge, K. H. et al. The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load. Clin. Exp. Immunol. 181, 457\u2013467 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"2489_CR24","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.1301653","volume":"191","author":"C Lau","year":"2013","unstructured":"Lau, C. et al. Chimeric anti-CD14 IgG\/4 hybrid antibodies for therapeutic intervention in pig and human models of inflammation. J. Immunol. 191, 4769\u20134777 (2013).","journal-title":"J. Immunol."},{"key":"2489_CR25","first-page":"1869","volume":"100","author":"TE Mollnes","year":"2002","unstructured":"Mollnes, T. E. et al. Essential role of the C5a receptor in E. coli\u2013induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869\u20131877 (2002).","journal-title":"Blood"},{"key":"2489_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","volume":"56","author":"G Bergseth","year":"2013","unstructured":"Bergseth, G. et al. An international serum standard for application in assays to detect human complement activation products. Mol. Immunol. 56, 232\u2013239 (2013).","journal-title":"Mol. Immunol."},{"key":"2489_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/653531","volume":"51","author":"LJ Schlapbach","year":"2010","unstructured":"Schlapbach, L. J. et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin. Infect. Dis. 51, 153\u2013162 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"2489_CR28","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/379324","volume":"37","author":"DP Eisen","year":"2003","unstructured":"Eisen, D. P. & Minchinton, R. M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis. 37, 1496\u20131505 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"2489_CR29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.addr.2011.05.010","volume":"63","author":"M Harboe","year":"2011","unstructured":"Harboe, M., Thorgersen, E. B. & Mollnes, T. E. Advances in assay of complement function and activation. Adv. Drug Deliv. Rev. 63, 976\u2013987 (2011).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2489_CR30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcrc.2014.11.007","volume":"30","author":"X Zhao","year":"2015","unstructured":"Zhao, X., Chen, Y.-X. & Li, C.-S. Predictive value of the complement system for sepsis-induced disseminated intravascular coagulation in septic patients in emergency department. J. Crit. Care 30, 290\u2013295 (2015).","journal-title":"J. Crit. Care"},{"key":"2489_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fped.2017.00014","volume":"5","author":"SL Raymond","year":"2017","unstructured":"Raymond, S. L. et al. Immunological defects in neonatal sepsis and potential therapeutic approaches. Front. Pediatr. 5, 14 (2017).","journal-title":"Front. Pediatr."},{"key":"2489_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2007.07.004","volume":"39","author":"MA Mohamed","year":"2007","unstructured":"Mohamed, M. A., Cunningham-Rundles, S., Dean, C. R., Hammad, T. A. & Nesin, M. Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 39, 171\u2013177 (2007).","journal-title":"Cytokine"},{"key":"2489_CR33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1651-2227.2012.02650.x","volume":"101","author":"HC \u00d8sterholt","year":"2012","unstructured":"\u00d8sterholt, H. C., Lundeland, B., Sonerud, T., Saugstad, O. D. & Nakstad, B. The impact of hyaluronan on monocyte toll\u2010like receptor expression in term infant cord blood. Acta Paediatr. 101, 706\u2013713 (2012).","journal-title":"Acta Paediatr."},{"key":"2489_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000112541","volume":"94","author":"AF Tatad","year":"2008","unstructured":"Tatad, A. F. et al. Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology 94, 8\u201315 (2008).","journal-title":"Neonatology"},{"key":"2489_CR35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000047130","volume":"80","author":"M Krueger","year":"2001","unstructured":"Krueger, M. et al. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Neonatology 80, 118\u2013123 (2001).","journal-title":"Neonatology"},{"key":"2489_CR36","doi-asserted-by":"crossref","unstructured":"B\u00fcscher, U. et al. IL-1\u03b2, IL-6, IL-8 and G-CSF in the diagnosis of early-onset neonatal infections. J. Perinat. Med. 28, 383\u2013388 (2000).","DOI":"10.1515\/JPM.2000.049"},{"key":"2489_CR37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1203\/00006450-200203000-00007","volume":"51","author":"R Berner","year":"2002","unstructured":"Berner, R., Welter, P. & Brandis, M. Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr. Res. 51, 304\u2013309 (2002).","journal-title":"Pediatr. Res."},{"key":"2489_CR38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00006454-200003000-00013","volume":"19","author":"F Kashlan","year":"2000","unstructured":"Kashlan, F. et al. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr. Infect. Dis. J. 19, 238\u2013243 (2000).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2489_CR39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","volume":"73","author":"P Garred","year":"2021","unstructured":"Garred, P., Tenner, A. J. & Mollnes, T. E. Therapeutic targeting of the complement system: from rare diseases to pandemics. Pharmacol. Rev. 73, 792\u2013827 (2021).","journal-title":"Pharmacol. Rev."},{"key":"2489_CR40","doi-asserted-by":"crossref","first-page":"E6390","DOI":"10.1073\/pnas.1706818114","volume":"114","author":"RS Keshari","year":"2017","unstructured":"Keshari, R. S. et al. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc. Natl Acad. Sci. USA 114, E6390\u2013E6399 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2489_CR41","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/pbc.25068","volume":"61","author":"UM Reiss","year":"2014","unstructured":"Reiss, U. M. et al. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria. Pediatr. Blood Cancer 61, 1544\u20131550 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"2489_CR42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum, L. A. et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 89, 701\u2013711 (2016).","journal-title":"Kidney Int."},{"key":"2489_CR43","first-page":"158","volume":"14","author":"DP Olszyna","year":"2003","unstructured":"Olszyna, D. P. et al. Effect of IC14, an anti\u2010CD14 antibody, on plasma and cell\u2010associated chemokines during human endotoxemia. Eur. Cytokine Netw. 14, 158\u2013162 (2003).","journal-title":"Eur. Cytokine Netw."},{"key":"2489_CR44","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.1400341","volume":"192","author":"M Huber-Lang","year":"2014","unstructured":"Huber-Lang, M. et al. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice. J. Immunol. 192, 5324\u20135331 (2014).","journal-title":"J. Immunol."},{"key":"2489_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-1129-9","volume":"19","author":"EW Skjeflo","year":"2015","unstructured":"Skjeflo, E. W. et al. Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis. Crit. Care 19, 1\u20138 (2015).","journal-title":"Crit. Care"},{"key":"2489_CR46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/IDR.S106181","volume":"9","author":"B Nakstad","year":"2016","unstructured":"Nakstad, B., Sonerud, T. & Solev\u00e5g, A. L. Early detection of neonatal group B Streptococcus sepsis and the possible diagnostic utility of IL-6, IL-8, and CD11b in a human umbilical cord blood in vitro model. Infect. Drug Resist. 9, 171 (2016).","journal-title":"Infect. Drug Resist."},{"key":"2489_CR47","doi-asserted-by":"crossref","first-page":"840288","DOI":"10.3389\/fped.2022.840288","volume":"10","author":"J Eichberger","year":"2022","unstructured":"Eichberger, J., Resch, E. & Resch, B. Diagnosis of neonatal sepsis: the role of inflammatory markers. Front. Pediatr. 10, 840288 (2022).","journal-title":"Front. Pediatr."},{"key":"2489_CR48","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/iai.10.6.1315-1320.1974","volume":"10","author":"JH Mathews","year":"1974","unstructured":"Mathews, J. H., Klesius, P. H. & Zimmerman, R. A. Opsonin system of the group B Streptococcus. Infect. Immun. 10, 1315\u20131320 (1974).","journal-title":"Infect. Immun."},{"key":"2489_CR49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.imlet.2005.09.005","volume":"102","author":"DW Draper","year":"2006","unstructured":"Draper, D. W., Bethea, H. N. & He, Y.-W. Toll-like receptor 2-dependent and-independent activation of macrophages by Group B Streptococci. Immunol. Lett. 102, 202\u2013214 (2006).","journal-title":"Immunol. Lett."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02489-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:12:37Z","timestamp":1690549957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02489-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Regional Ethical Committee (2019\/834\/REK nord). All participating women gave informed written consent to participate in the study. All participants signed a written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}